Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

The p-MYH9/USP22/HIF-1α axis promotes lenvatinib resistance and cancer stemness in hepatocellular carcinoma.

  • Authors : Shan Q; Department of Hepatobiliary and Pancreatic Surgery, NHC Key Laboratory of Combined Multi-organ Transplantation, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310058, China.; Yin L

Subjects: Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/genetics ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/pathology ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/drug therapy

  • Source: Signal transduction and targeted therapy [Signal Transduct Target Ther] 2024 Sep 19; Vol. 9 (1), pp. 249. Date of Electronic Publication: 2024 Sep 19.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101676423 Publication Model: Electronic Cited

Record details

×
Academic Journal

Enhanced efficacy of combined VEGFR peptide-drug conjugate and anti-PD-1 antibody in treating hepatocellular carcinoma.

  • Authors : Liu J; Department of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, People's Republic of China.; Hubei Province Key Laboratory of Molecular Imaging, Wuhan, China.

Subjects: Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/drug therapy ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/pathology ; Liver Neoplasms*/Liver Neoplasms*/Liver Neoplasms*/drug therapy

  • Source: Scientific reports [Sci Rep] 2024 Sep 17; Vol. 14 (1), pp. 21728. Date of Electronic Publication: 2024 Sep 17.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited

Record details

×
Academic Journal

Combined DeRitis ratio and alkaline phosphatase on the prediction of portal vein tumor thrombosis in patients with hepatocellular carcinoma.

  • Authors : Miao TG; Department of Traditional and Western Medical Hepatology, Hebei Medical University Third Hospital, Shijiazhuang, 050017, Hebei, People's Republic of China.; Zhang SY

Subjects: Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/complications ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/pathology ; Liver Neoplasms*/Liver Neoplasms*/Liver Neoplasms*/pathology

  • Source: Scientific reports [Sci Rep] 2024 Sep 16; Vol. 14 (1), pp. 21614. Date of Electronic Publication: 2024 Sep 16.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited

Record details

×
Academic Journal

Alpha lipoic acid diminishes migration and invasion in hepatocellular carcinoma cells through an AMPK-p53 axis.

  • Authors : Hidalgo F; Institute of Experimental Physiology (IFISE), School of Biochemical and Pharmaceutical Sciences, CONICET-University of Rosario, Suipacha 570, S2002LRL, Rosario, Argentina.; Ferretti AC

Subjects: Thioctic Acid*/Thioctic Acid*/Thioctic Acid*/pharmacology ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/metabolism ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/pathology

  • Source: Scientific reports [Sci Rep] 2024 Sep 11; Vol. 14 (1), pp. 21275. Date of Electronic Publication: 2024 Sep 11.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited

Record details

×
Academic Journal

Artificial intelligence for ultrasonographic detection and diagnosis of hepatocellular carcinoma and cholangiocarcinoma.

  • Authors : Chaiteerakij R; Center of Excellence for Innovation and Endoscopy in Gastrointestinal Oncology, Division of Gastroenterology, Department of Medicine, Faculty of Medicine, Chulalongkorn University, 1873 Rama IV Road, Patumwan, Bangkok, 10330, Thailand. .; Ariyaskul D

Subjects: Cholangiocarcinoma*/Cholangiocarcinoma*/Cholangiocarcinoma*/diagnostic imaging ; Cholangiocarcinoma*/Cholangiocarcinoma*/Cholangiocarcinoma*/diagnosis ; Cholangiocarcinoma*/Cholangiocarcinoma*/Cholangiocarcinoma*/pathology

  • Source: Scientific reports [Sci Rep] 2024 Sep 04; Vol. 14 (1), pp. 20617. Date of Electronic Publication: 2024 Sep 04.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited

Record details

×
Academic Journal

Apelin (APLN) is a biomarker contributing to the diagnosis and prognosis of hepatocellular carcinoma.

  • Authors : Mao X; State Key Laboratory of Virology, College of Life Sciences, Wuhan University, Wuhan, China.; Frontier Science Center for Immunology and Metabolism, Wuhan University, Wuhan, China.

Subjects: Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/diagnosis ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/genetics ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/metabolism

  • Source: Scientific reports [Sci Rep] 2024 Sep 03; Vol. 14 (1), pp. 20441. Date of Electronic Publication: 2024 Sep 03.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited

Record details

×
Academic Journal

Titration of RAS alters senescent state and influences tumour initiation.

  • Authors : Chan ASL; Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge, UK.; Zhu H

Subjects: Cellular Senescence* ; Liver Neoplasms*/Liver Neoplasms*/Liver Neoplasms*/pathology ; Liver Neoplasms*/Liver Neoplasms*/Liver Neoplasms*/genetics

  • Source: Nature [Nature] 2024 Sep; Vol. 633 (8030), pp. 678-685. Date of Electronic Publication: 2024 Aug 07.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 0410462 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

Ubiquitin-specific protease 1 facilitates hepatocellular carcinoma progression by modulating mitochondrial fission and metabolic reprogramming via cyclin-dependent kinase 5 stabilization.

  • Authors : Bian S; Research Center of Clinical Medicine, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China.; Department of Oncology, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China.

Subjects: Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/pathology ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/metabolism ; Liver Neoplasms*/Liver Neoplasms*/Liver Neoplasms*/pathology

  • Source: Cell death and differentiation [Cell Death Differ] 2024 Sep; Vol. 31 (9), pp. 1202-1218. Date of Electronic Publication: 2024 Jul 15.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 9437445 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

The tRNA Gm18 methyltransferase TARBP1 promotes hepatocellular carcinoma progression via metabolic reprogramming of glutamine.

  • Authors : Shi X; Department of Human Cell Biology and Genetics, Joint Laboratory of Guangdong & Hong Kong Universities for Vascular Homeostasis and Diseases, School of Medicine; Shenzhen Key Laboratory of Gene Regulation and Systems Biology, Southern University of Science and Technology, Shenzhen, 518055, China.

Subjects: Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/metabolism ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/pathology ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/genetics

  • Source: Cell death and differentiation [Cell Death Differ] 2024 Sep; Vol. 31 (9), pp. 1219-1234. Date of Electronic Publication: 2024 Jun 12.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 9437445 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

SMYD5 is a ribosomal methyltransferase that catalyzes RPL40 lysine methylation to enhance translation output and promote hepatocellular carcinoma.

  • Authors : Miao B; Shanghai Key Laboratory of Medical Epigenetics, International Co-laboratory of Medical Epigenetics and Metabolism, Ministry of Science and Technology, Institutes of Biomedical Sciences, Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education, Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China.; Ge L

Subjects: Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/metabolism ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/pathology ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/genetics

  • Source: Cell research [Cell Res] 2024 Sep; Vol. 34 (9), pp. 648-660. Date of Electronic Publication: 2024 Aug 05.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 9425763 Publication Model: Print-Electronic Cited

Record details

×
  • 1-10 of  2,250 results for ""Carcinoma, Hepatocellular""